HomeTagsGracell Biotechnologies

Gracell Biotechnologies

Biotechnology

Gracell Biotechnologies Presents Updated Clinical Data for BCMA/CD19 Dual-targeting FasTCAR GC012F

PR Newswire - June 14, 2022

Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, announced the...

Biotechnology

Gracell Biotechnologies to Present Data at AACR Annual Meeting 2022

PR Newswire - April 11, 2022

Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, announced the...

Biotechnology

Gracell Biotechnologies Doses First Patients in First-in-Human Clinical Trial Evaluating

PR Newswire - February 18, 2022

Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, announced that...